Search
for
Sort by
Research 901–930 of 1000+
- 84 Partial restoration of scalp microbiota in alopecia areata with JAK inhibitors
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- Real-world evidence in alopecia areata treatment: A narrative review
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial
- Assessment of vitamin D levels in patients with alopecia areata: a case-control study in a Tertiary Care Hospital in North India
- Association Between Alopecia Areata and High‐Sensitivity Cardiac Troponin T as a Marker of Subclinical Myocardial Injury
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Sodium chloride reduces growth and cytosolic calcium, but does not affect cytosolic pH, in root hairs of Arabidopsis thaliana L.
- A Large Cross-Sectional Survey Study of the Prevalence of Alopecia Areata in the United States
- Encapsulation characteristics of protein hydrolysate extracted from Ziziphus jujube seed
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- A Study of Correlation of Alopecia Areata and Metabolic Syndrome in Northwest Indian Population
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Efficacy of a mixed preparation containing piperine, capsaicin and curcumin in the treatment of alopecia areata
- The Role of Tofacitinib in the Management of Alopecia Totalis
- Subclinical Atherosclerosis in Alopecia Areata: Usefulness of Arterial Ultrasound for Disease Diagnosis and Analysis of Its Relationship with Cardiometabolic Parameters
- A Case of Alopecia Totalis with Lichen Planus Hypertrophicus Responded Excellently to Oral Tofacitinib-An Observation
- A randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areata
- LB943 Tofacitinib treatment of inflammatory skin conditions in patients with Down Syndrome
- Exotic pediculosis and hair-loss syndrome in deer (<i>Odocoileus hemionus</i>) populations in California
- Enhancing germination performance and vigor of lettuce and napa cabbage seeds through simple seed priming techniques under controlled conditions
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study